183 related articles for article (PubMed ID: 20454619)
1. Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model.
Hajdin K; D'Alessandro V; Niggli FK; Schäfer BW; Bernasconi M
PLoS One; 2010 May; 5(5):e10445. PubMed ID: 20454619
[TBL] [Abstract][Full Text] [Related]
2. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
3. The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells.
Jaaks P; Meier G; Alijaj N; Brack E; Bode P; Koscielniak E; Wachtel M; Schäfer BW; Bernasconi M
Oncotarget; 2016 Nov; 7(47):76743-76755. PubMed ID: 27572312
[TBL] [Abstract][Full Text] [Related]
4. Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma.
Roveri M; Pfohl A; Jaaks P; Alijaj N; Leroux JC; Luciani P; Bernasconi M
Nanomedicine (Lond); 2017 May; 12(10):1135-1151. PubMed ID: 28447920
[TBL] [Abstract][Full Text] [Related]
5. Implication of the proprotein convertases in iron homeostasis: proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin.
Guillemot J; Canuel M; Essalmani R; Prat A; Seidah NG
Hepatology; 2013 Jun; 57(6):2514-24. PubMed ID: 23390091
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z
J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026
[TBL] [Abstract][Full Text] [Related]
7. Identification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumour lymphatic-homing peptide LyP-1.
Witt H; Hajdin K; Iljin K; Greiner O; Niggli FK; Schäfer BW; Bernasconi M
Int J Cancer; 2009 May; 124(9):2026-32. PubMed ID: 19123480
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
Tian S; Jianhua W
Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
[TBL] [Abstract][Full Text] [Related]
10. Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.
Lissitzky JC; Luis J; Munzer JS; Benjannet S; Parat F; Chrétien M; Marvaldi J; Seidah NG
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):133-8. PubMed ID: 10657249
[TBL] [Abstract][Full Text] [Related]
11. Shedding of cancer susceptibility candidate 4 by the convertases PC7/furin unravels a novel secretory protein implicated in cancer progression.
Duval S; Abu-Thuraia A; Elkholi IE; Chen R; Seebun D; Mayne J; Côté JF; Figeys D; Seidah NG
Cell Death Dis; 2020 Aug; 11(8):665. PubMed ID: 32820145
[TBL] [Abstract][Full Text] [Related]
12. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
13. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
Bassi DE; Zhang J; Renner C; Klein-Szanto AJ
Mol Carcinog; 2017 Mar; 56(3):1182-1188. PubMed ID: 27584082
[TBL] [Abstract][Full Text] [Related]
14. Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.
Dzhumashev D; Anton-Joseph S; Morel VJ; Timpanaro A; Bordon G; Piccand C; Aleandri S; Luciani P; Rössler J; Bernasconi M
Eur J Pharm Biopharm; 2024 Jan; 194():49-61. PubMed ID: 38029941
[TBL] [Abstract][Full Text] [Related]
15. C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.
Zenitani M; Nojiri T; Uehara S; Miura K; Hosoda H; Kimura T; Nakahata K; Miyazato M; Okuyama H; Kangawa K
Cancer Med; 2016 May; 5(5):795-805. PubMed ID: 26816265
[TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors of prohormone convertases 1 and 2 using a peptide combinatorial library.
Apletalina E; Appel J; Lamango NS; Houghten RA; Lindberg I
J Biol Chem; 1998 Oct; 273(41):26589-95. PubMed ID: 9756897
[TBL] [Abstract][Full Text] [Related]
17. Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens.
Shiryaev SA; Remacle AG; Ratnikov BI; Nelson NA; Savinov AY; Wei G; Bottini M; Rega MF; Parent A; Desjardins R; Fugere M; Day R; Sabet M; Pellecchia M; Liddington RC; Smith JW; Mustelin T; Guiney DG; Lebl M; Strongin AY
J Biol Chem; 2007 Jul; 282(29):20847-53. PubMed ID: 17537721
[TBL] [Abstract][Full Text] [Related]
18. Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis.
Layne JD; Shridas P; Webb NR
J Biol Chem; 2015 Mar; 290(12):7851-60. PubMed ID: 25623068
[TBL] [Abstract][Full Text] [Related]
19. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
20. Quantum Dot-Based Screening Identifies F3 Peptide and Reveals Cell Surface Nucleolin as a Therapeutic Target for Rhabdomyosarcoma.
Dzhumashev D; Timpanaro A; Ali S; De Micheli AJ; Mamchaoui K; Cascone I; Rössler J; Bernasconi M
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
